ResMed CEO Mick Farrell has become the first leader from the home care sector to chair the board of directors at AdvaMed, the trade association representing major medtech companies.

Michael “Mick” Farrell, chairman and CEO of Resmed, has begun his two-year term as the new chair of AdvaMed’s board of ...

The market expects ResMed (RMD) to deliver a year-over-year increase in earnings on higher revenues when it reports results ...

Based on Resmed’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.34 billion and a net profit of $348.54 million. In comparison, last year ...

Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including ...

Resmed has announced that Kylie Canaday has been appointed chief strategy officer, officially stepping into the role on Jan. 16.

ResMed (NYSE:RMD) supports global respiratory care as s&p 500 chart discussions frame large healthcare organizations.

Image from Insulet website] BVI announced today that it appointed Jim Hollingshead as its new president and CEO. Hollingshead ...

If you are wondering whether ResMed's current share price still offers value, this article walks through what the numbers are ...

Canaday was named chief of staff for the executive team at Resmed in January 2022. Later that year, she moved into the ...

With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, ...